Hypothesis
Metabolic syndrome components would shape the clinical picture of LRRK2- and GBA-associated Parkinson's disease and the prodromal burden in unaffected carriers.
What failed
Across 562 participants (idiopathic, LRRK2 and GBA Parkinson's, non-manifesting carriers and non-carrier controls), the number of metabolic syndrome components did not differ between Parkinson's groups (p = 0.101) or between carrier groups (p = 0.685).
Broken assumption
Metabolic syndrome modifies how genetic Parkinson's disease presents.
Why
Only isolated components differed — higher triglycerides and more prediabetes in LRRK2 carriers — and the authors conclude metabolic syndrome as a whole does not appear to modify the genetic Parkinson's phenotype.
From the published paper: Thaler et al. Scientific Reports, 2020. ↗CC BY